What research is needed to characterise HPV E2 as an oncoprotein?
Best insight from top research papers
To characterize the Human Papillomavirus (HPV) E2 protein as an oncoprotein, a multifaceted research approach is necessary, focusing on its role in viral replication, transcription regulation, post-translational modifications, and interactions with host cell proteins. Firstly, understanding the role of E2 in the regulation of viral replication is crucial. Studies have shown that E2 is essential for initiating viral DNA replication through its interaction with the viral genome and cellular replication machinery. Further research should explore the functional interaction between E2 and cellular DNA polymerase epsilon (pol ε), as E2 has been found to stimulate the DNA synthesis activity of pol ε, indicating a specific role beyond E1 recruitment in viral DNA replication. Secondly, the transcriptional regulation by E2, including its impact on viral oncoprotein expression and the persistence of episomal HPV genomes, needs further investigation. E2's interaction with the cellular DNA helicase ChlR1, necessary for viral genome tethering, represents a potential therapeutic target. Additionally, the modulation of cellular gene expression by E2 in HPV-infected cells suggests its involvement in oncogenic processes. Thirdly, post-translational modifications (PTMs) of E2, such as phosphorylation and acetylation, play significant roles in its function. Phosphorylation of specific serine residues affects E2's ability to support viral gene transcription and replication, while acetylation of lysine residues is necessary for transcription and DNA replication. Research into the enzymes responsible for these PTMs and their impact on E2 function could provide insights into the oncogenic potential of E2. Lastly, the interaction of E2 with host cell proteins, including its nuclear import mechanism, is a critical area of study. Identifying the nuclear import receptor for E2 and the role of dimerization in its nuclear localization could reveal new aspects of its function in the viral life cycle and oncogenesis. In summary, characterizing HPV E2 as an oncoprotein requires a comprehensive research strategy that addresses its roles in viral replication, transcription regulation, post-translational modifications, and interactions with host cell proteins.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| Research is needed to explore HPV E2's oncogenic potential, focusing on its DNA binding preferences, oligomerization, and interactions with replication origin elements to understand its role in cancer development. | |
| Characterization of the conserved cysteine residue in HPV E2 protein is crucial for understanding its role in viral biology and potential implications for HPV-associated cancers. | |
| Not addressed in the paper. | |
| Research is needed to identify the protein kinase(s) responsible for phosphorylating E2 serine residue 402 and further characterize HPV5 E2's role in replication and transcription for oncogenic potential. |
Related Questions
What is the current understanding regardig UCP2 and HPV?5 answersCurrent research suggests that UCP2 plays a significant role in cancer, including cervical cancer. Studies have shown that UCP2 is highly expressed in various cancers, including cervical cancer, and its expression levels correlate with tumor progression and metastasis. UCP2 has been linked to metabolic reprogramming in cancer cells, promoting the Warburg effect and influencing cellular metabolism towards oxidative phosphorylation. Moreover, UCP2 expression levels have been associated with the effectiveness of neoadjuvant chemotherapy in locally advanced cervical cancer, with low UCP2 expression predicting better response to treatment. These findings suggest that UCP2 may serve as a potential biomarker for predicting treatment outcomes and prognosis in cervical cancer patients, highlighting its importance in understanding and managing HPV-related malignancies.
What is the molecular mechanism by which HPV E1 cdk mutant results in no E2 phosphorylation?5 answersThe molecular mechanism by which an HPV E1 CDK mutant results in no E2 phosphorylation can be understood through the interplay of various proteins and phosphorylation processes involved in the HPV life cycle. The E1 protein, a helicase essential for viral replication, interacts with E2, a transcription and replication factor, to regulate the viral genome's transcription, replication, and maintenance within the host cell. Phosphorylation plays a crucial role in modulating the activities of these proteins. For instance, CK2 phosphorylation of the bovine papillomavirus E1 and E2 proteins modifies their DNA binding activity, which is a critical regulatory mechanism during the viral life cycle. However, when specific sites within the E1 nuclear localization signal, conserved for phosphorylation by kinase CK2, are mutated, there is no observed change in the replication phenotype or the subcellular distribution of E1, indicating that phosphorylation at these sites does not regulate viral DNA replication in dividing cells.
The E2 protein itself is subject to phosphorylation, which influences its interaction with other proteins and its ability to regulate viral processes. For example, CK2 phosphorylation of HPV16 E2 promotes interaction with TopBP1, critical for the viral life cycle. Similarly, FGFR3 phosphorylates HPV-31 E2 at tyrosine 138, affecting its interaction with Brd4, necessary for initiating viral DNA synthesis. However, mutations in the conserved cysteine residue of E2, which might be expected to affect its function, do not impair its transcriptional activity or nuclear localization, suggesting that phosphorylation of E2 at other sites is more critical for its role in the viral life cycle.
Given this background, an HPV E1 CDK mutant would result in no E2 phosphorylation if the mutation disrupts the interaction between E1 and the kinases responsible for E2 phosphorylation or alters the conformation of E1 in a way that impedes its ability to facilitate or participate in the phosphorylation of E2. This disruption could prevent the phosphorylation-dependent modulation of E2's functions, such as its interaction with other proteins and its ability to regulate transcription and replication of the viral genome.
What are the molecular mechanisms by which HPV E2 promotes viral replication and persistence in human cells?5 answersThe E2 protein of Human Papillomavirus (HPV) plays a pivotal role in promoting viral replication and persistence in human cells through a series of molecular mechanisms. Firstly, E2 is a transcriptional activator that participates in the E1-dependent replication and nuclear retention of the viral genome. Phosphorylation of the E2 protein, particularly at serine residue 402, is essential for the transcription and replication of the HPV genome, as demonstrated in HPV type 5 (HPV5). This phosphorylation does not affect E2's stability, subcellular localization, or DNA-binding capacity but is crucial for its transcriptional activity.
Moreover, E2 interacts with the tumor suppressor protein p53, forming heterotypic condensates that modulate HPV gene function, dependent on the host cell's replication and transcription machinery. This interaction suggests a complex regulatory mechanism where E2 not only promotes viral replication but also potentially influences cellular pathways to favor viral persistence.
The conserved cysteine residue within the E2 DNA contact helix, although not necessary for replication or DNA binding, suggests a role in the viral life cycle potentially related to the release of viral DNA during progeny virion packaging. Additionally, E2's interaction with host chromatin, facilitated by CK2 phosphorylation at serine 23, is crucial for the segregation of the HPV genome into daughter nuclei, ensuring viral replication in subsequent cell cycles. This interaction with TopBP1 is essential for E2's plasmid segregation activity and for maintaining E2 and viral genome stability.
The degradation of E2 in the absence of TopBP1 interaction, as seen with the S23A mutation, highlights the importance of this interaction in preventing viral genome integration and maintaining the episomal state of the virus. Furthermore, quantitative analysis of E2's binding to its DNA targets underscores the specificity of these interactions in regulating viral DNA replication. Lastly, the phosphorylation of E2 by CK2 and its interaction with TopBP1 are critical for E2's plasmid retention function and the HPV16 life cycle, suggesting potential therapeutic targets for disrupting HPV persistence.
Together, these mechanisms underscore the multifaceted role of E2 in ensuring HPV replication and persistence within human cells, involving specific post-translational modifications, interactions with cellular proteins, and regulation of viral and host DNA.
What is the molecular mechanism by which HPV E4 contributes to the development and progression of cancer?4 answersThe molecular mechanism by which HPV E4 contributes to the development and progression of cancer is not mentioned in the provided abstracts.
Which drugs targeting e6 or e7 HPV?5 answersThere are several drugs targeting the HPV E6 and E7 oncoproteins. REBACIN® has been shown to inhibit the growth of cervical cancer cells by targeting E6/E7 expression both in vitro and in vivo. Anti-E6 antibodies/antibody fragments, including Camelidae-derived single-domain antibodies (sdAbs), have been developed as diagnostic and detection tools, but their therapeutic potential requires further development and testing. Single-chain antibodies (scFvs) against HPV16 E6 and E7 have demonstrated antitumor activity and delayed tumor progression in preclinical models, suggesting their potential as a safe and effective treatment for HPV16-associated lesions. Nanoparticles composed of a non-viral vector and a CRISPR/Cas9 recombinant plasmid targeting HPV16 E7 have shown promise in inhibiting tumor growth and reversing the malignant phenotype of cervical epithelial cells. An mRNA-based vaccine targeting HPV16 E6 and E7 has also been developed and shown to elicit an antigen-specific immune response, inhibiting tumor growth and extending lifespan in mice with HPV16+ lesions.
Does HPV E2 interact with host histone?5 answersThe papillomavirus E2 protein interacts with host histones, specifically inducing epigenetic histone modifications of the hTERT promoter. E2 binding to cellular chromatin is observed in both mitotic and interphase cells, and it strongly correlates with histone H3 acetylation and K4 trimethylation, indicators of active transcription. The E2 protein recruits host cell factors to the HPV regulatory region, regulating viral transcription, replication, and mitotic segregation of the viral genome. Additionally, the E2 protein associates with the cohesion establishment factor ChlR1, contributing to a loading mechanism during DNA replication. The E2 protein also targets highly connected cellular proteins involved in transcriptional regulation, apoptosis, RNA metabolism, ubiquitination, and intracellular transport. Therefore, the interaction between HPV E2 and host histones plays a crucial role in viral transcriptional regulation and the hijacking of host cell processes during HPV infection.